about
Comprehensive proteomic analysis of breast cancer cell membranes reveals unique proteins with potential roles in clinical cancerFT-IR microspectrometry reveals the variation of membrane polarizability due to epigenomic effect on epithelial ovarian cancerAdvances in molecular therapies in patients with brain tumors.Gefitinib therapy for advanced non-small-cell lung cancer.Targeting EGFR and HER-2 with cetuximab- and trastuzumab-mediated immunotherapy in oesophageal squamous cell carcinomaActivator protein 2alpha mediates parathyroid TGF-alpha self-induction in secondary hyperparathyroidism.A phase II and pharmacodynamic study of gefitinib in patients with refractory or recurrent epithelial ovarian cancer.Integrative oncoproteomics strategies for anticancer drug discovery.Epidermal growth factor receptor double targeting by a tyrosine kinase inhibitor (Iressa) and a monoclonal antibody (Cetuximab). Impact on cell growth and molecular factors.A critical role for enhanced TGF-alpha and EGFR expression in the initiation of parathyroid hyperplasia in experimental kidney disease.
P2860
Q24329242-0379740E-B80F-46A8-808E-742672EAE941Q34486707-B991456C-E6FA-4603-BCD6-8C146306175EQ35113656-A440F454-9EF6-4786-BA54-9CC499D51673Q35562614-78664A79-CF99-4C71-B068-1286A80290A9Q36611021-D91D9590-800D-4719-BFB9-20FEBEB2B224Q36906034-4BE78407-8EB9-455F-A7BB-31F9E3175617Q37423291-55EB95FA-2AF8-421B-8D5F-2FF3BBFF6B6CQ37763937-F5AB692A-C5FF-4B6D-95C4-834366AAFBB6Q40448827-9973CB66-7A76-423F-ADAB-C8337D4D1D90Q53667768-BC29AFB5-56CB-4CB6-B22F-A50E133E6B85
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
ZD1839 (IRESSA): a selective EGFR-TK inhibitor.
@ast
ZD1839 (IRESSA): a selective EGFR-TK inhibitor.
@en
type
label
ZD1839 (IRESSA): a selective EGFR-TK inhibitor.
@ast
ZD1839 (IRESSA): a selective EGFR-TK inhibitor.
@en
prefLabel
ZD1839 (IRESSA): a selective EGFR-TK inhibitor.
@ast
ZD1839 (IRESSA): a selective EGFR-TK inhibitor.
@en
P2093
P2860
P356
P1476
ZD1839 (IRESSA): a selective EGFR-TK inhibitor.
@en
P2093
Gordon Jayson
Malcolm Ranson
Was Mansoor
P2860
P304
P356
10.1586/14737140.2.2.161
P577
2002-04-01T00:00:00Z